8 August 2018 - CEO Larry Merlo says prices are rising faster for medicines with smaller manufacturer rebates.
CVS Health Chief Executive Larry Merlo said Wednesday that industry middlemen aren’t responsible for increasing U.S. drug prices, noting that prices are rising faster for medicines with smaller manufacturer rebates.
CVS owns Caremark, one of the biggest pharmacy benefit managers, which process prescriptions for insurers or companies that pay for medicines and use their size to negotiate with drugmakers and pharmacies.